| Aerosol generating treatments or diagnostics for respiratory or cardiac conditions (acute pulmonary oedema) during the COVID-19 pandemic period
|
SESLHDBR/094 |
|
| Clinical Pathway Guideline
|
SESLHDGL/037 |
|
| Continuous Positive Airway Pressure (CPAP) and Non Invasive Ventilation (NIV) Domiciliary Device use by Inpatients with previously diagnosed obstructive sleep apnoea/sleep related breathing disorder
|
SESLHDPR/434 |
|
Heparin - Anticoagulation with Intravenous Heparin Sodium Infusion (Adults)
|
SESLHDPR/402 |
|
| Intra-Pleural Fibrinolysis - Medical Management of Empyema
|
SESLHDPR/631 |
|
| Medicine: Frusemide use in Adult Chronic Heart Failure Patients
|
SESLHDPD/169 |
|
| Procedural Sedation (Adults, Ward, Clinic and Imaging areas)
|
SESLHDPR/528 |
|
Reducing Cardiothoracic Surgical Site Infections through use of a Cardiothoracic Surgical Site Infection Care Bundle Guideline
|
SESLHDGL/066 |
|
| Rifapentine for treatment of latent tuberculosis
|
SESLHDPR/678 |
|
| Standard short-course therapy for Tuberculosis (TB) with Fixed Dose Combination tablets
|
SESLHDPR/657 |
|
| Tracheostomy Clinical Management Procedures for Adult Inpatients
|
SESLHDPR/298 |
|
